Found: 7
Select item for more details and to access through your institution.
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 12, p. 1, doi. 10.15252/emmm.202317719
- By:
- Publication type:
- Article
Quels traitements pour le mélanome uvéal ?
- Published in:
- Médecine Sciences, 2022, v. 38, n. 8/9, p. 733, doi. 10.1051/medsci/2022112
- By:
- Publication type:
- Article
Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1194, doi. 10.3390/cancers14051194
- By:
- Publication type:
- Article
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 96, doi. 10.3390/cancers14010096
- By:
- Publication type:
- Article
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5691, doi. 10.3390/cancers13225691
- By:
- Publication type:
- Article
Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
- Published in:
- Cancers, 2018, v. 10, n. 3, p. 70, doi. 10.3390/cancers10030070
- By:
- Publication type:
- Article